Polypill and RiscOMeter to Prevent StrOke and CogniTive ImpairmEnt (PROMOTE)
A phase 3 trial registered on ClinicalTrials.gov. The registry status is recruiting. It plans to enroll 8518 participants.
Also called NCT05155137
- Study
- In this atlas
Overview
- Design
- Interventional study; randomized; quadruple masking; primary purpose prevention
- Phase
- Phase 3
- Enrolled
- 8,518 participants
- Registry
-
NCT05155137
-
- Started
- (actual)
- Primary completion
- (anticipated)
- Completion
- (anticipated)
- Countries
- Brazil
- Registry status
- Recruiting
Technical summary
Registry record NCT05155137. Randomized; quadruple masking; primary purpose prevention. Start 2021-12-20 (actual); primary completion 2029-12-14 (anticipated). Results not posted.
The registry's words
Labels as the registry gives them, not rewritten.
- Brief title
- Polypill and RiscOMeter to Prevent StrOke and CogniTive ImpairmEnt (PROMOTE)
- Acronym
- PROMOTE
- Condition
- Stroke
- Condition
- Cognitive Decline
- Intervention (Drug)
- Drug Capsule (Valsartan + Amlodipine + Rosuvastatin)
- Intervention (Behavioral)
- Stroke Riskometer
- Lead sponsor
- Hospital Moinhos de Vento
- Collaborator
- Ministry of Health, Brazil
- Collaborator
- World Stroke Organization
Record details
- Record id
cardio:ct-nct05155137- Content hash
cd12cf9129ad8351c96bc96973331c7d106c6f65630b7e255def1410b7cbe908